Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Placebo Controlled Trial of Metformin Treatment in Progressive Multiple Sclerosis

NCT05349474 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05349474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05349474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Placebo Controlled Trial of Metformin Treatment in Progressive Multiple Sclerosis
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Completed
Start date
April 26, 2022
Completion date
May 30, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary progressive multiple sclerosis, secondary progressive multiple sclerosis